Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

The 2018 ACC/AHA Lipid Guidelines: A Little More or Less Canadian?

Thanassoulis G, Gregoire J, Pearson GJ.

Can J Cardiol. 2019 May;35(5):558-563. doi: 10.1016/j.cjca.2019.03.003. Epub 2019 Mar 19. No abstract available.

PMID:
31030858
2.
3.

Cardiovascular Efficacy and Safety of PCSK9 Inhibitors: Systematic Review and Meta-analysis Including the ODYSSEY OUTCOMES Trial.

Turgeon RD, Tsuyuki RT, Gyenes GT, Pearson GJ.

Can J Cardiol. 2018 Dec;34(12):1600-1605. doi: 10.1016/j.cjca.2018.04.002.

PMID:
30527147
4.

Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018.

Brunham LR, Ruel I, Aljenedil S, Rivière JB, Baass A, Tu JV, Mancini GBJ, Raggi P, Gupta M, Couture P, Pearson GJ, Bergeron J, Francis GA, McCrindle BW, Morrison K, St-Pierre J, Henderson M, Hegele RA, Genest J, Goguen J, Gaudet D, Paré G, Romney J, Ransom T, Bernard S, Katz P, Joy TR, Bewick D, Brophy J.

Can J Cardiol. 2018 Dec;34(12):1553-1563. doi: 10.1016/j.cjca.2018.09.005.

PMID:
30527143
5.

Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update.

Tobe SW, Stone JA, Anderson T, Bacon S, Cheng AYY, Daskalopoulou SS, Ezekowitz JA, Gregoire JC, Gubitz G, Jain R, Keshavjee K, Lindsay P, L'Abbe M, Lau DCW, Leiter LA, O'Meara E, Pearson GJ, Rabi DM, Sherifali D, Selby P, Tu JV, Wharton S, Walker KM, Hua-Stewart D, Liu PP.

CMAJ. 2018 Oct 9;190(40):E1192-E1206. doi: 10.1503/cmaj.180194. No abstract available.

6.

Remote Pharmacist Practice Model of Collaboration in Primary Care: Potential for Benefit or an Opportunity Lost?

Pearson GJ.

Circ Cardiovasc Qual Outcomes. 2018 Jun;11(6):e004801. doi: 10.1161/CIRCOUTCOMES.118.004801. No abstract available.

PMID:
29884658
7.

Proprotein convertase subtilisin/kexin type 9 inhibitors for reduction of cardiovascular events.

Turgeon RD, Pearson GJ.

Am J Health Syst Pharm. 2018 Jun 1;75(11):747-754. doi: 10.2146/ajhp170707. Review.

PMID:
29802110
8.

Prevention and management of statin adverse effects: A practical approach for pharmacists.

Barry AR, Beach JE, Pearson GJ.

Can Pharm J (Ott). 2018 Apr 4;151(3):179-188. doi: 10.1177/1715163518768534. eCollection 2018 May-Jun.

9.

A review of the use of direct oral anticoagulant use in orthotopic heart transplantation recipients.

Boswell R, Pearson GJ.

Transplant Rev (Orlando). 2018 Jul;32(3):151-156. doi: 10.1016/j.trre.2018.04.002. Epub 2018 Apr 16. Review. No abstract available.

PMID:
29720347
10.

Comment: Should an LDL Cholesterol Target-Based Approach Be Readopted?

Turgeon RD, Pearson GJ.

Ann Pharmacother. 2018 Jul;52(7):706-707. doi: 10.1177/1060028018765941. Epub 2018 Mar 20. No abstract available.

PMID:
29557207
11.

Pharmacologic Treatment of Patients With Myocardial Ischemia With No Obstructive Coronary Artery Disease.

Turgeon RD, Pearson GJ, Graham MM.

Am J Cardiol. 2018 Apr 1;121(7):888-895. doi: 10.1016/j.amjcard.2017.12.025. Epub 2018 Jan 10.

PMID:
29394999
12.

2016 Guidelines for the management of dyslipidemia and the prevention of cardiovascular disease in adults by pharmacists.

Turgeon RD, Anderson TJ, Grégoire J, Pearson GJ.

Can Pharm J (Ott). 2017 Jul 7;150(4):243-250. doi: 10.1177/1715163517713031. eCollection 2017 Jul-Aug. No abstract available.

13.

The Past, the Present, and a Very Bright Future.

Pearson GJ.

Can J Hosp Pharm. 2017 Jul-Aug;70(4):328. Epub 2017 Aug 31. No abstract available.

14.

Le passé, le présent et un avenir très radieux.

Pearson GJ.

Can J Hosp Pharm. 2017 Jul-Aug;70(4):327. Epub 2017 Aug 31. French. No abstract available.

PMID:
28894323
Free PMC Article
15.

The Pursuit of Professional Practice Excellence and the Achievement of Peer Recognition.

Pearson GJ.

Can J Hosp Pharm. 2017 Jan-Feb;70(1):92. Epub 2017 Feb 28. No abstract available.

16.

La recherche de l’excellence en pratique professionnelle et l’obtention de la reconnaissance des pairs.

Pearson GJ.

Can J Hosp Pharm. 2017 Jan-Feb;70(1):91. Epub 2017 Feb 28. French. No abstract available.

PMID:
28348438
Free PMC Article
17.

2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult.

Anderson TJ, Grégoire J, Pearson GJ, Barry AR, Couture P, Dawes M, Francis GA, Genest J Jr, Grover S, Gupta M, Hegele RA, Lau DC, Leiter LA, Lonn E, Mancini GB, McPherson R, Ngui D, Poirier P, Sievenpiper JL, Stone JA, Thanassoulis G, Ward R.

Can J Cardiol. 2016 Nov;32(11):1263-1282. doi: 10.1016/j.cjca.2016.07.510. Epub 2016 Jul 25. Review.

PMID:
27712954
18.
19.

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016).

Mancini GB, Baker S, Bergeron J, Fitchett D, Frohlich J, Genest J, Gupta M, Hegele RA, Ng D, Pearson GJ, Pope J, Tashakkor AY.

Can J Cardiol. 2016 Jul;32(7 Suppl):S35-65. doi: 10.1016/j.cjca.2016.01.003. Epub 2016 Jan 14. Review.

PMID:
27342697
20.

Belonging to CSHP-An Investment in Your Future and That of Hospital Pharmacy!

Pearson GJ.

Can J Hosp Pharm. 2016 Mar-Apr;69(2):180. Epub 2016 Apr 29. No abstract available.

21.

Faire partie de la SCPH - un investissement dans votre avenir et celui de la pharmacie hospitalière!

Pearson GJ.

Can J Hosp Pharm. 2016 Mar-Apr;69(2):179. Epub 2016 Apr 29. French. No abstract available.

22.

Familial hypercholesterolemia: Review of diagnosis, screening, and treatment.

Turgeon RD, Barry AR, Pearson GJ.

Can Fam Physician. 2016 Jan;62(1):32-7. Review.

23.

Updated guidelines for the management of dyslipidemia and prevention of cardiovascular disease by pharmacists.

Turgeon RD, Anderson TJ, Grégoire J, Pearson GJ.

Can Pharm J (Ott). 2015 Jan;148(1):21-8. doi: 10.1177/1715163514561256. No abstract available.

24.

A Change of Seasons-A New Beginning!

Pearson GJ.

Can J Hosp Pharm. 2015 Sep-Oct;68(5):436. No abstract available.

25.

Un changement de saison, un nouveau départ!

Pearson GJ.

Can J Hosp Pharm. 2015 Sep-Oct;68(5):435. French. No abstract available.

26.

Correlation of cardiovascular magnetic resonance imaging findings and endomyocardial biopsy results in patients undergoing screening for heart transplant rejection.

Butler CR, Savu A, Bakal JA, Toma M, Thompson R, Chow K, Wang H, Kim DH, Mengel M, Haykowsky M, Pearson GJ, Kaul P, Paterson I.

J Heart Lung Transplant. 2015 May;34(5):643-50. doi: 10.1016/j.healun.2014.12.020. Epub 2015 Jan 8.

PMID:
25934478
27.

A new year-time for reconciliation.

Pearson GJ.

Can J Hosp Pharm. 2015 Jan-Feb;68(1):96. No abstract available.

28.

Une nouvelle année : l'heure est au bilan.

Pearson GJ.

Can J Hosp Pharm. 2015 Jan-Feb;68(1):95. No abstract available.

29.

Professional use of social media by pharmacists.

Barry AR, Pearson GJ.

Can J Hosp Pharm. 2015 Jan-Feb;68(1):22-7.

30.

Adverse drug reactions: The importance of maintaining pharmacovigilance.

Barry AR, Koshman SL, Pearson GJ.

Can Pharm J (Ott). 2014 Jul;147(4):233-8. doi: 10.1177/1715163514536523. Review. No abstract available.

31.

Cardiovascular MRI predicts 5-year adverse clinical outcome in heart transplant recipients.

Butler CR, Kim DH, Chow K, Toma M, Thompson R, Mengel M, Haykowsky M, Pearson GJ, Paterson I.

Am J Transplant. 2014 Sep;14(9):2055-61. doi: 10.1111/ajt.12811. Epub 2014 Aug 6.

32.

Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.

Barry AR, Koshman SL, Norris CM, Ross DB, Pearson GJ.

Pharmacotherapy. 2014 May;34(5):464-72.

PMID:
24877186
33.

Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel.

Anderson TJ, Grégoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J Jr, Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA, Ur E.

Can J Cardiol. 2014 Apr;30(4):377-80. doi: 10.1016/j.cjca.2014.01.009. Epub 2014 Jan 17. No abstract available.

PMID:
24589194
34.

Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update.

Mancini GB, Tashakkor AY, Baker S, Bergeron J, Fitchett D, Frohlich J, Genest J, Gupta M, Hegele RA, Ng DS, Pearson GJ, Pope J.

Can J Cardiol. 2013 Dec;29(12):1553-68. doi: 10.1016/j.cjca.2013.09.023. Epub 2013 Sep 29.

PMID:
24267801
35.

An evaluation of teaching physical examination to pharmacists.

Barry AR, McCarthy L, Nelson CL, Pearson GJ.

Can Pharm J (Ott). 2012 Jul;145(4):174-179.e1. doi: 10.3821/145.4.cpj174.

36.

2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.

Anderson TJ, Grégoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J Jr, Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA, Ur E.

Can J Cardiol. 2013 Feb;29(2):151-67. doi: 10.1016/j.cjca.2012.11.032. Review.

PMID:
23351925
37.

The interaction of various liquids with long-term denture soft lining materials.

Liao WC, Pearson GJ, Braden M, Wright PS.

Dent Mater. 2012 Oct;28(10):e199-206. doi: 10.1016/j.dental.2012.04.036. Epub 2012 May 17.

PMID:
22608162
38.

Frequency of intensive statin therapy in patients with acute coronary syndrome admitted to a tertiary care center.

Shiu JR, Pearson GJ, Charrois TL, Gyenes G, Koshman SL.

Am J Cardiol. 2012 Jan 1;109(1):1-5. doi: 10.1016/j.amjcard.2011.07.064. Epub 2011 Oct 6.

PMID:
21981973
39.

The effect of ultrasound on the setting reaction of zinc polycarboxylate cements.

Shahid S, Billington RW, Hill RG, Pearson GJ.

J Mater Sci Mater Med. 2010 Nov;21(11):2901-5. doi: 10.1007/s10856-010-4146-x. Epub 2010 Aug 18.

PMID:
20717709
40.

Secondary stroke prevention: practice patterns in a tertiary care stroke service.

Fan JC, Mysak TM, Jeerakathil TJ, Pearson GJ.

Can J Neurol Sci. 2010 Mar;37(2):245-51.

PMID:
20437937
41.

Prescribing by Pharmacist's and Collaborative Care: Are We Ready to Accept the Baton and Get in the Race?

Barry AR, Pearson GJ.

Can J Hosp Pharm. 2010 Jan;63(1):59. No abstract available.

42.

In vitro colonization of an experimental silicone by Candida albicans.

Rodger G, Taylor RL, Pearson GJ, Verran J.

J Biomed Mater Res B Appl Biomater. 2010 Jan;92(1):226-35. doi: 10.1002/jbm.b.31509.

PMID:
19921746
43.

Colchicine for the primary and secondary prevention of pericarditis: an update.

Kuo If, Pearson GJ, Koshman SL.

Ann Pharmacother. 2009 Dec;43(12):2075-81. doi: 10.1345/aph.1M234. Epub 2009 Nov 10. Review.

PMID:
19903861
44.

Kinetics of fluoride ion release from dental restorative glass ionomer cements: the influence of ultrasound, radiant heat and glass composition.

Thanjal NK, Billington RW, Shahid S, Luo J, Hill RG, Pearson GJ.

J Mater Sci Mater Med. 2010 Feb;21(2):589-95. doi: 10.1007/s10856-009-3901-3. Epub 2009 Oct 23.

PMID:
19851843
45.

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.

Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, Couture P, Dufour R, Fodor G, Francis GA, Grover S, Gupta M, Hegele RA, Lau DC, Leiter L, Lewis GF, Lonn E, Mancini GB, Ng D, Pearson GJ, Sniderman A, Stone JA, Ur E.

Can J Cardiol. 2009 Oct;25(10):567-79. Review.

46.

Kinetics of fluoride release from glass components of glass ionomers.

Luo J, Billington RW, Pearson GJ.

J Dent. 2009 Jul;37(7):495-501. doi: 10.1016/j.jdent.2009.02.007. Epub 2009 Apr 10.

PMID:
19361904
47.

Monitoring of mycophenolate mofetil in orthotopic heart transplant recipients--a systematic review.

Zuk DM, Pearson GJ.

Transplant Rev (Orlando). 2009 Jul;23(3):171-7. doi: 10.1016/j.trre.2009.02.002. Epub 2009 Apr 2. Review.

PMID:
19345081
48.

Maintenance of improved lipid levels following attendance at a cardiovascular risk reduction clinic: a 10-year experience.

Pearson GJ, Olson KL, Panich NE, Majumdar SR, Tsuyuki RT, Gilchrist DM, Damani A, Francis GA.

Vasc Health Risk Manag. 2008;4(5):1127-35.

49.

Effect of ultrasound on the setting characteristics of glass ionomer cements studied by Fourier transform infrared spectroscopy.

Talal A, Tanner KE, Billington R, Pearson GJ.

J Mater Sci Mater Med. 2009 Jan;20(1):405-11. doi: 10.1007/s10856-008-3578-z. Epub 2008 Sep 25.

PMID:
18815732
50.

The role of glass composition in the behaviour of glass acetic acid and glass lactic acid cements.

Shahid S, Billington RW, Pearson GJ.

J Mater Sci Mater Med. 2008 Feb;19(2):541-5. Epub 2007 Jul 10.

PMID:
17619992

Supplemental Content

Loading ...
Support Center